EXPOSED: Angelina Jolie part of a Clever Corporate Scheme to protect Billions in BRCA Gene Patents, influence Supreme Court decision
Angelina Jolie's announcement of undergoing a double mastectomy (surgically removing both breasts) even though she had no breast cancer is not the innocent, spontaneous, "heroic choice" that has been portrayed in the mainstream media.
We believe it all coincides with a well-timed for-profit corporate P.R. campaign that has been planned for months and just happens to coincide with the upcoming U.S. Supreme Court decision on the viability of the BRCA1 patent.The signs were all there from the beginning of the scheme: Angelina Jolie's highly polished and obviously corporate-written op-ed piece at the New York Times, the carefully-crafted talking points invoking "choice" as a politically-charged keyword, and the obvious coaching of even her husband Brad Pitt who carefully describes the entire experience using words like "stronger" and "pride" and "family."
But the smoking gun is the fact that Angelina Jolie's seemingly spontaneous announcement magically appeared on the cover of People Magazine this week -- a magazine that is usually finalized for publication three weeks before it appears on newsstands. That cover, not surprisingly, uses the same language found in the NYT op-ed piece: "HER BRAVE CHOICE" and "This was the right thing to do." The flowery, pro-choice language is not a coincidence.
What this proves is that Angelina's Jolie's announcement was a well-planned corporate P.R. campaign with carefully-crafted messages designed to influence public opinion. But what could Jolie be seeking to influence?
...how about trillions of dollars in corporate profits? -